http://purl.org/np/RAeEtl1ACsglKfaCRp7srHTmAihji7azu2FWj6yFdwHMY
.trig | .trig.txt | .jelly | .jelly.txt
@prefix orcid: <https://orcid.org/> . @prefix this: <http://purl.org/np/RAeEtl1ACsglKfaCRp7srHTmAihji7azu2FWj6yFdwHMY> . @prefix sub: <http://purl.org/np/RAeEtl1ACsglKfaCRp7srHTmAihji7azu2FWj6yFdwHMY#> . @prefix np: <http://www.nanopub.org/nschema#> . @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:3uitj0kw&rows=> . @prefix ns1: <http://wordnet-rdf.princeton.edu/lemma/> . @prefix prov: <http://www.w3.org/ns/prov#> . @prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:> . @prefix npx: <http://purl.org/nanopub/x/> . sub:Head { this: a np:Nanopublication; np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo . } sub:assertion { <https://uts.nlm.nih.gov/uts/umls/concept/C0392920> ns1:associate <https://uts.nlm.nih.gov/uts/umls/concept/C1518321> . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T20:03:50.382077"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "with good outcomes among select patients with newly diagnosed or stage I / II NK / T-LAHLH" . rdf:OBJECT-POSITION rdfs:label "45"^^xsd:integer . rdf:PREDICATE rdfs:label "associated" . rdf:PREDICATE-POSITION rdfs:label "[229]" . rdf:SUBJECT rdfs:label "etoposide + dexamethasone-based chemotherapy regimens" . rdf:SUBJECT-POSITION rdfs:label "202"^^xsd:integer . rdfs:ABSTRACT-UID ns2:50 "3uitj0kw" . rdfs:SENTENCE rdfs:label "Although patients with hemophagocytic lymphohistiocytosis (NK)/T-LAHLH), which is a rare and fatal disease with no effective therapy generally experienced poor outcomes, etoposide + dexamethasone-based chemotherapy regimens were associated with good outcomes among select patients with newly diagnosed or stage I/II NK/T-LAHLH." . rdfs:TRIPLE-UID ns3:3uitj0kw-TRIPLE-ABSTRACT-19 "3uitj0kw-TRIPLE-ABSTRACT-19" . <https://uts.nlm.nih.gov/uts/umls/concept/C0392920> rdfs:label "chemotherapy regimens" . <https://uts.nlm.nih.gov/uts/umls/concept/C1518321> rdfs:label "newly diagnosed" . } sub:pubInfo { sub:assertion prov:wasDerivedFrom <https://doi.org/10.1007/s00432-020-03376-7> . sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "ZJJjUPniqgfLEtvSbXFG+mprJYzaA54PsxWzijksvVcYX3gbHL0QR7RgJ6qFCE9FBKJfZvd1L78SWcnPfzzmci7fym19ODJf8cX/liJ56JmvCyS6Wp4aJ7Z8ekWYU4gmAbmLfJEvm414Tp7lUOS3RZ0EiDCVwFGhQTKTBm+6EcI="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T20:03:50.382077"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-8954-0470 . }